Relevate Health

Intended audience

This broadcast is intended for US healthcare providers involved in the treatment of obesity.

PROGRAM OVERVIEW

Join a multidisciplinary expert panel as they underscore the urgent need for comprehensive care for obesity management that addresses both cardiovascular (CV) risk and chronic weight management in appropriate adult patients. The panel will analyze and provide insights into the efficacy and safety data from multiple randomized, controlled trials. Building on this foundation, they will also explore real-world evidence on the use of obesity medication on weight loss and CV risk reduction in routine clinical practice.

{REMOTELIVEEVENTS}

Available via

Broadcast Schedule

The broadcast will be available at various times throughout the day, depending on your time zone. Reference the chart below for a complete list of broadcast times.

You may participate in any or all webcast sessions.

Daytime Broadcast: Tuesday, June 10, 2025

EASTERN	CENTRAL	MOUNTAIN	PACIFIC
12:15 PM	11:15 AM	10:15 AM	9:15 AM
1:15 PM	12:15 PM	11:15 AM	10:15 AM
2:15 PM	1:15 PM	12:15 PM	11:15 AM
3:15 PM	2:15 PM	1:15 PM	12:15 PM

Daytime Broadcast: Wednesday, June 11, 2025

EASTERN	CENTRAL	MOUNTAIN	PACIFIC
12:15 PM	11:15 AM	10:15 AM	9:15 AM
1:15 PM	12:15 PM	11:15 AM	10:15 AM
2:15 PM	1:15 PM	12:15 PM	11:15 AM
3:15 PM	2:15 PM	1:15 PM	12:15 PM

Evening Broadcast: Tuesday, June 17, 2025

EASTERN	CENTRAL	MOUNTAIN	PACIFIC
7:00 PM	6:00 PM	5:00 PM	4:00 PM
8:00 PM	7:00 PM	6:00 PM	5:00 PM
9:00 PM	8:00 PM	7:00 PM	6:00 PM
10:00 PM	9:00 PM	8:00 PM	7:00 PM

This promotional program is developed by Novo Nordisk.

Novo Nordisk is a registered trademark of Novo Nordisk A/S.